SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
SMMT fundamentals
During Q4 2025, Summit Therapeutics (SMMT) reported revenue of --, a YoY change of 0.00%. Net income was -219.17M, a YoY change of -258.11%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2018 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | May 1, 2017 | May 1, 2018 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jul 31, 2017 | Jul 31, 2018 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jan 31 | Jan 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 6.27M -- | 53.36M +751.33% | 148.00K -- | 0 -- | 324.00K -- | 170.00K -99.68% | 181.00K +22.30% | 185.00K -- | 192.00K -40.74% | 57.00K -66.47% | 1.31M +623.20% | 251.00K +35.68% | 250.00K +30.21% | 235.00K +312.28% | 220.00K -83.19% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Sales and Services Revenue | 6.27M -- | 49.82M +694.82% | 148.00K -- | -- -- | 324.00K -- | 170.00K -99.66% | 181.00K +22.30% | 185.00K -- | 192.00K -40.74% | 57.00K -66.47% | 1.31M +623.20% | 251.00K +35.68% | 250.00K +30.21% | 235.00K +312.28% | 220.00K -83.19% | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Revenue | -- -- | 3.54M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 6.27M -- | 53.36M +751.33% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | 6.30M -- | -- -- | 6.82M -- | 3.82M -- | 4.31M -31.56% | 4.36M -- | 5.45M -20.10% | 6.12M +60.21% | 4.81M +11.63% | 4.59M +5.18% | 4.81M -11.78% | 3.01M -50.75% | 5.46M +13.56% | 1.13M -75.31% | 584.00K -87.85% | -- -- | 0 -100.00% | -54.00K -104.77% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 12.00M -- | 21.21M +76.73% | 12.63M -- | -- -- | 16.48M -- | 19.35M -8.80% | 21.43M +69.63% | 16.10M -- | 22.56M +36.88% | 29.91M +54.59% | 25.61M +19.48% | 30.89M +91.80% | 27.21M +20.61% | 15.94M -46.70% | 22.62M -11.65% | 21.43M -30.61% | 537.74M +1875.89% | 15.79M -0.92% | 20.49M -9.42% | 36.16M +68.70% | 42.39M -92.12% | 59.62M +277.47% | 58.38M +184.88% | 65.61M +81.47% | 66.85M +57.71% | 568.44M +853.48% | 234.21M +301.20% | 224.93M +242.80% | 1.09B -- |
Selling, General and Administrative Expenses | 3.28M -- | 3.55M +8.22% | 2.68M -- | -- -- | 3.57M -- | 5.77M +62.51% | 6.85M +155.16% | 3.04M -- | 4.18M +17.16% | 5.98M +3.64% | 5.66M -17.29% | 7.78M +155.92% | 6.66M +59.12% | 6.93M +15.86% | 5.57M -1.57% | 7.58M -2.60% | 6.94M +4.22% | 6.32M -8.90% | 5.43M -2.49% | 10.57M +39.54% | 11.52M +65.94% | 13.81M +118.68% | 20.65M +280.09% | 14.23M +34.59% | 15.59M +35.34% | 360.42M +2509.44% | 103.11M +399.25% | 77.63M +445.48% | 556.75M -- |
General and Administrative Expenses | -- -- | -- -- | 2.68M -- | -- -- | 3.57M -- | 5.77M -- | 6.85M +155.16% | 3.04M -- | 4.18M +17.16% | 5.98M +3.64% | 5.66M -17.29% | 7.78M +155.92% | 6.66M +59.12% | 6.93M +15.86% | 5.57M -1.57% | 7.58M -2.60% | 6.94M +4.22% | 6.32M -8.90% | 5.43M -2.49% | 10.57M +39.54% | 11.52M +65.94% | 13.81M +118.68% | 20.65M +280.09% | 14.23M +34.59% | 15.59M +35.34% | 360.42M +2509.44% | 103.11M +399.25% | 77.63M +445.48% | 556.75M -- |
Research and Development Expenses | 8.72M -- | 12.43M +42.53% | 9.95M -- | -- -- | 12.91M -- | 13.57M +9.20% | 13.73M +37.94% | 13.06M -- | 18.38M +42.34% | 23.92M +76.27% | 19.94M +45.29% | 23.11M +76.88% | 20.56M +11.85% | 9.01M -62.35% | 17.05M -14.51% | 5.39M -76.69% | 530.80M +2482.20% | 9.45M +4.92% | 15.06M -11.68% | 25.58M +374.97% | 30.87M -94.18% | 30.80M +225.87% | 37.72M +150.52% | 51.38M +100.85% | 51.27M +66.05% | 208.02M +575.44% | 131.10M +247.51% | 147.29M +186.66% | 537.67M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 859.00K -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 8.47M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | -- -- | 5.23M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 27.00K -- | -- -- | -- -- | -- -- | 15.01M +55481.48% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- |
Operating Income | -5.73M -- | 32.15M +660.59% | -6.19M -- | -- -- | -9.34M -- | -15.36M -147.76% | -16.94M -173.68% | -11.56M -- | -16.92M -81.19% | -23.73M -54.53% | -19.49M -15.02% | -26.05M -125.40% | -22.16M -30.93% | -12.69M +46.51% | -16.94M +13.07% | -20.30M +22.07% | -537.15M -2324.20% | -15.79M -24.44% | -20.49M -20.97% | -36.21M -78.38% | -42.39M +92.11% | -59.62M -277.47% | -58.38M -184.88% | -65.61M -81.20% | -66.85M -57.71% | -568.44M -853.48% | -234.21M -301.20% | -224.93M -242.80% | -1.09B -- |
Non-Operating Income (Loss) | -287.67K -- | 3.47M +1306.77% | -75.00K -- | -- -- | 3.26M -- | -114.00K -103.28% | -858.00K -1044.00% | -2.01M -- | -565.00K -117.33% | -686.00K -501.75% | -113.00K +86.83% | -1.05M +47.56% | 761.00K +234.69% | -4.08M -494.61% | -4.45M -3833.63% | 1.07M +201.71% | -5.22M -786.20% | 1.08M +126.40% | -776.00K +82.54% | -357.00K -133.36% | -1.08M +79.24% | -768.00K -171.31% | 2.12M +373.71% | 4.41M +1335.57% | 3.94M +463.28% | 2.73M +455.34% | 2.42M +13.84% | 5.75M +30.42% | 14.84M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.51M -- | -- -- | -- -- | 2.48M -- | 2.38M +56.97% | 1.83M -- | 2.58M -- | 4.34M +74.53% | 4.72M +98.82% | 3.86M +111.10% | 2.98M +15.63% | 2.78M -35.90% | 5.88M +24.50% | 15.50M -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 54.00K -- | -- -- | -- -- | -- -- | -2.13M -4053.70% | -- -- | -- -- | -- -- | -4.11M -92.46% | -- -- | -- -- | -475.00K -- | 269.00K +106.55% | 208.00K -- | -244.00K -- | 241.00K +150.74% | -302.00K -212.27% | 77.00K -62.98% | -199.00K +18.44% | -362.00K -250.21% | -126.00K +58.28% | -610.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -75.00K -- | -- -- | 3.26M -- | -114.00K -- | -858.00K -1044.00% | -1.81M -- | -565.00K -117.33% | -686.00K -501.75% | -113.00K +86.83% | 1.32M +173.24% | 761.00K +234.69% | -4.08M -494.61% | -4.45M -3833.63% | 8.07M +508.83% | -5.22M -786.20% | 1.08M +126.40% | -64.00K +98.56% | -104.00K -101.29% | -- -- | 0 -100.00% | 0 +100.00% | 0 +100.00% | -- -- | -53.00K -- | 0 -- | 0 -- | -- -- |
Net Interest Expense | 287.67K -- | -3.47M -1306.77% | -- -- | -- -- | -- -- | -- -- | -- -- | 251.00K -- | -- -- | -- -- | -- -- | 242.00K -3.59% | -- -- | -- -- | -- -- | 4.40M +1718.60% | -- -- | -- -- | 2.72M -- | 2.90M -34.17% | 3.12M -- | 3.10M -- | 2.45M -9.85% | 9.00K -99.69% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -- -- |
Interest Expense | 288.99K -- | 183.75K -36.42% | -- -- | -- -- | -- -- | -- -- | -- -- | 255.00K -- | -- -- | -- -- | -- -- | 242.00K -5.10% | -- -- | -- -- | -- -- | 4.40M +1718.60% | -- -- | -- -- | 2.72M -- | 2.90M -34.17% | 3.12M -- | 3.10M -- | 2.45M -9.85% | 9.00K -99.69% | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -- -- |
Interest Income | 1.32K -- | 3.66M +276901.55% | -- -- | -- -- | -- -- | -- -- | -- -- | 4.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -6.02M -- | 35.62M +691.45% | -6.26M -- | -11.62M -- | -6.08M -- | -15.47M -143.43% | -17.80M -184.10% | -13.56M -16.70% | -17.49M -187.68% | -24.42M -57.83% | -19.60M -10.11% | -27.10M -99.82% | -21.40M -22.35% | -16.77M +31.31% | -21.39M -9.11% | -19.23M +29.04% | -542.38M -2434.82% | -14.72M +12.25% | -21.27M +0.55% | -36.57M -90.17% | -43.47M +91.98% | -60.38M -310.31% | -56.25M -164.50% | -61.20M -67.37% | -62.91M -44.72% | -565.71M -836.84% | -231.79M -312.05% | -219.17M -258.11% | -1.08B -- |
Income Tax Expense | -1.69M -- | 644.44K +138.06% | 111.00K -- | 0 -- | 55.00K -- | -191.00K -129.64% | -56.00K -150.45% | -21.00K -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -213.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -4.33M -- | 34.98M +907.85% | -6.38M -- | -11.62M -- | -6.13M -- | -15.28M -143.68% | -17.74M -178.28% | -13.54M -16.52% | -17.49M -185.10% | -24.42M -59.80% | -19.60M -10.46% | -27.10M -100.13% | -21.40M -22.35% | -16.77M +31.31% | -21.39M -9.11% | -19.23M +29.04% | -542.38M -2434.82% | -14.72M +12.25% | -21.27M +0.55% | -36.57M -90.17% | -43.47M +91.98% | -60.38M -310.31% | -56.25M -164.50% | -61.20M -67.37% | -62.91M -44.72% | -565.71M -836.84% | -231.79M -312.05% | -219.17M -258.11% | -1.08B -- |
Net Income Attributable to Owners of the Company | -4.33M -- | 34.98M +907.85% | -6.38M -- | -- -- | -6.13M -- | -15.28M -143.68% | -17.74M -178.28% | -13.54M -- | -17.49M -185.10% | -24.42M -59.80% | -19.60M -10.46% | -27.10M -100.13% | -21.40M -22.35% | -16.77M +31.31% | -21.39M -9.11% | -19.23M +29.04% | -542.38M -2434.82% | -14.72M +12.25% | -21.27M +0.55% | -36.57M -90.17% | -43.47M +91.98% | -60.38M -310.31% | -56.25M -164.50% | -61.20M -67.37% | -62.91M -44.72% | -565.71M -836.84% | -231.79M -312.05% | -219.17M -258.11% | -1.08B -- |
Net Income Attributable to Common Stockholders | -4.33M -- | 34.98M +907.85% | -6.38M -- | -- -- | -6.13M -- | -15.28M -143.68% | -17.74M -178.28% | -13.54M -- | -17.49M -185.10% | -24.42M -59.80% | -19.60M -10.46% | -27.10M -100.13% | -21.40M -22.35% | -16.77M +31.31% | -21.39M -9.11% | -19.23M +29.04% | -542.38M -2434.82% | -14.72M +12.25% | -21.27M +0.55% | -36.57M -90.17% | -43.47M +91.98% | -60.38M -310.31% | -56.25M -164.50% | -61.20M -67.37% | -62.91M -44.72% | -565.71M -836.84% | -231.79M -312.05% | -219.17M -258.11% | -1.08B -- |
Other Comprehensive Income | 9.24K -- | 15.75K +70.51% | -1.25M -- | 1.35M -- | -4.62M -- | -52.00K -430.16% | 2.33M +285.34% | 3.32M +145.93% | 675.00K +114.60% | 540.00K +1138.46% | -863.00K -137.10% | 1.25M -62.50% | -1.76M -360.74% | 789.00K +46.11% | -49.00K +94.32% | 1.32M +6.35% | 498.00K +128.30% | -1.04M -231.94% | 114.00K +332.65% | -125.00K -109.44% | -1.00K -100.20% | 50.00K +104.80% | 191.00K +67.54% | 23.00K +118.40% | -278.00K -27700.00% | -189.00K -478.00% | 43.00K -77.49% | 169.00K +634.78% | -255.00K -- |
Total Comprehensive Income | -4.32M -- | 34.99M +909.94% | -7.63M -- | -10.27M -- | -10.76M -- | -15.33M -143.81% | -15.42M -102.03% | -10.22M +0.49% | -16.81M -56.28% | -23.88M -55.74% | -20.46M -32.72% | -25.85M -152.95% | -23.16M -37.73% | -15.98M +33.06% | -21.43M -4.75% | -17.91M +30.75% | -541.88M -2240.02% | -15.76M +1.40% | -21.15M +1.31% | -36.69M -104.93% | -43.47M +91.98% | -60.34M -282.88% | -56.06M -165.02% | -61.18M -66.74% | -63.19M -45.35% | -565.90M -837.92% | -231.75M -313.37% | -219.00M -257.97% | -1.08B -- |
Total Comprehensive Income Attributable to Owners of the Company | -4.32M -- | 34.99M +909.94% | -7.63M -- | -- -- | -10.76M -- | -15.33M -143.81% | -15.42M -102.03% | -10.22M -- | -16.81M -56.28% | -23.88M -55.74% | -20.46M -32.72% | -25.85M -152.95% | -23.16M -37.73% | -15.98M +33.06% | -21.43M -4.75% | -17.91M +30.75% | -541.88M -2240.02% | -15.76M +1.40% | -21.15M +1.31% | -36.69M -104.93% | -43.47M +91.98% | -60.34M -282.88% | -56.06M -165.02% | -61.18M -66.74% | -63.19M -45.35% | -565.90M -837.92% | -231.75M -313.37% | -219.00M -257.97% | -1.08B -- |
Basic EPS | -0.07 -- | 0.42 +700.00% | -0.2 -- | -0.03 -- | -0.09 -- | -0.23 -154.76% | -0.26 -30.00% | -0.41 -1266.67% | -0.21 -133.33% | -0.27 -17.39% | -0.2 +23.08% | -0.5 -21.95% | -0.15 +28.57% | -0.12 +55.56% | -0.1 +50.00% | -0.09 +82.00% | -1.43 -853.33% | -0.02 +83.33% | -0.03 +70.00% | -0.05 +44.44% | -0.06 +95.80% | -0.09 -350.00% | -0.08 -166.67% | -0.08 -60.00% | -0.09 -50.00% | -0.76 -744.44% | -0.31 -287.50% | -0.28 -250.00% | -1.44 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -0.2 -- | -- -- | -0.09 -- | -0.23 -- | -0.26 -30.00% | -- -- | -0.21 -133.33% | -0.27 -17.39% | -0.2 +23.08% | -- -- | -0.15 +28.57% | -0.12 +55.56% | -0.1 +50.00% | -- -- | -1.43 -853.33% | -0.02 +83.33% | -0.03 +70.00% | -- -- | -0.06 +95.80% | -0.09 -350.00% | -0.08 -166.67% | -- -- | -0.09 -50.00% | -0.76 -744.44% | -0.31 -287.50% | -- -- | -- -- |
Diluted EPS | -- -- | 0.42 -- | -0.2 -- | -- -- | -0.09 -- | -0.23 -154.76% | -0.26 -30.00% | -- -- | -0.21 -133.33% | -0.27 -17.39% | -0.2 +23.08% | -- -- | -0.15 +28.57% | -0.12 +55.56% | -0.1 +50.00% | -- -- | -1.43 -853.33% | -0.02 +83.33% | -0.03 +70.00% | -- -- | -0.06 +95.80% | -0.09 -350.00% | -0.08 -166.67% | -- -- | -0.09 -50.00% | -0.76 -744.44% | -0.31 -287.50% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -0.2 -- | -- -- | -0.09 -- | -0.23 -- | -0.26 -30.00% | -- -- | -0.21 -133.33% | -0.27 -17.39% | -0.2 +23.08% | -- -- | -0.15 +28.57% | -0.12 +55.56% | -0.1 +50.00% | -- -- | -1.43 -853.33% | -0.02 +83.33% | -0.03 +70.00% | -- -- | -0.06 +95.80% | -0.09 -350.00% | -0.08 -166.67% | -- -- | -0.09 -50.00% | -0.76 -744.44% | -0.31 -287.50% | -- -- | -- -- |
You can ask Aime
What is Summit Therapeutics's gross profit margin?What is the market's earnings forecast for Summit Therapeutics next quarter?What factors drove the changes in Summit Therapeutics's revenue and profit?What is the revenue and EPS growth rate for Summit Therapeutics year over year?What were the key takeaways from Summit Therapeutics’s earnings call?What were the key takeaways from Summit Therapeutics's earnings call?What does Summit Therapeutics do and what are its main business segments?What guidance did Summit Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
